Literature DB >> 25100918

Nine years of retained perfluoro-n-octane in the anterior chamber after retinal detachment repair with no signs of ocular toxicity.

Emad B Abboud1, M Al-Falah1.   

Abstract

Perfluoro-n-octane (PFO) is commonly used in vitreoretinal surgery. In this case report, we present a 35-year-old patient with retained PFO up to 9 years after par plana vitrectomy. Post-operatively, PFO bubbles occupied 15% of the anterior chamber (AC). Follow-up over 9 years, consistently showed a quiet AC, normal intraocular pressure and endothelial cell counts remained stable. Until date, the patient has been under observation and there have been no ocular symptoms or side-effects. Residual PFO that inadvertently remains in the AC can be well- tolerated, without side-effects for up to 9 years.

Entities:  

Keywords:  Anterior Chamber; Perfluoro-n-octane; Vitreo-retinal Surgery

Mesh:

Substances:

Year:  2014        PMID: 25100918      PMCID: PMC4123286          DOI: 10.4103/0974-9233.134697

Source DB:  PubMed          Journal:  Middle East Afr J Ophthalmol        ISSN: 0974-9233


  7 in total

1.  Retained perfluoron postvitreoretinal surgery causing secondary open-angle glaucoma.

Authors:  Daniela Toffoli; Jean-Daniel Arbour; Paul Harasymowycz
Journal:  Can J Ophthalmol       Date:  2008-06       Impact factor: 1.882

2.  Clinicopathologic findings in eyes with retained perfluoro-n-octane liquid.

Authors:  S H Elsing; S Fekrat; W R Green; S Chang; S D Wajer; J A Haller
Journal:  Ophthalmology       Date:  2001-01       Impact factor: 12.079

3.  Perfluoroperhydrophenanthrene versus perfluoro-n-octane in vitreoretinal surgery.

Authors:  A Loewenstein; M S Humayun; E de Juan; P A Campochiaro; J A Haller
Journal:  Ophthalmology       Date:  2000-06       Impact factor: 12.079

4.  Intraocular dispersion of perfluorocarbon liquids in silicone oil.

Authors:  Antonio P Ciardella; Kevin Langton; Stanley Chang
Journal:  Am J Ophthalmol       Date:  2003-08       Impact factor: 5.258

5.  Outcomes of surgery for retinal detachment associated with proliferative vitreoretinopathy using perfluoro-n-octane: a multicenter study.

Authors:  Ingrid U Scott; Harry W Flynn; Timothy G Murray; William J Feuer
Journal:  Am J Ophthalmol       Date:  2003-09       Impact factor: 5.258

6.  Experimental studies of tolerance to intravitreal perfluoro-n-octane liquid.

Authors:  S Chang; J R Sparrow; T Iwamoto; A Gershbein; R Ross; R Ortiz
Journal:  Retina       Date:  1991       Impact factor: 4.256

7.  Delayed inflammation associated with retained perfluorocarbon liquid.

Authors:  S Pradeep; Jay K Chhablani; Bhavin Patel; Padmaja Rani
Journal:  Indian J Ophthalmol       Date:  2011 Sep-Oct       Impact factor: 1.848

  7 in total
  1 in total

1.  Reversible Corneal Toxicity of Retained Intracameral Perfluoro-n-octane.

Authors:  Saad S Alharbi; Mohammed S Asiri
Journal:  Middle East Afr J Ophthalmol       Date:  2016 Jul-Sep
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.